Researchers a gene expression marker that distinguishes smokers with lung cancer signs from smokers without the disease.
Ads by Google
Endoscopic ultrasound can safely and effectively determine whether masses in or around the lungs are cancerous or benign.
Not all lung cancer is due to a lifetime of smoking cigarettes. Sometimes the diagnosis is a mystery.
Encouraging residents to test their homes for elevated levels of radon, second leading cause of lung cancer.
Rhode Island Department of Health recommends all homes be tested for radon.
Potential solution to cetuximab resistance in lung cancers.
DNA coughed up along with phlegm could point to signs of lung cancer.
Combination gene therapy delivered in lipid based nanoparticles drastically reduces the number and size of human non small cell lung cancer tumors in mice.
Patients treated surgically for early stage lung cancer face an increased risk of recurrence if their tumors contain a large number of cells that act as "dimmer switches" on the immune system.
Analysis of existing lung cancer studies shows that the use of gene expression profiling to assess a cancer prognosis has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.
Administering erlotinib, a drug that blocks growth signals, to non small cell lung cancer patients who have been previously treated with chemotherapy improves not only the length of survival for patients, but also their quality of life.
It could be possible to develop embryonic stem cell vaccines to prevent lung cancer and other types of hereditary cancers.
The ability to use Avastin as a lung cancer treatment method, along with chemotherapy, is a significant development for the lung cancer community.
FDA approves Avastin in combination with chemotherapy for first line treatment of most common type of lung cancer.
In some non small cell lung carcinomas researchers have shown that the tumor suppressor gene H REV107 1 may actually stimulate tumor progression.
Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum based drug commonly used to treat the disease.
Cancer drug developer Antisoma plc announces final data from its phase II trial of AS1404 in non small cell lung cancer.
While the effect is modest, the lung cancer risk can be higher if living close to heavy industry.
It may be possible to reverse drug resistance in lung cancer patients, thereby improving the effectiveness of chemotherapy.
Duke scientists have developed a genomic test to predict which patients with early stage lung cancer will need chemotherapy to live and which patients can avoid the toxic regimen of drugs.
Blood test can be used to save lives by identifing lung cancer years earlier than current imaging techniques.
Treating lung tumors with the enhanced Cyberknife requires only 1-3 sessions lasting 60 to 90 minutes.
Thermal ablation followed by radiation shown effective treatment for inoperable lung cancer.
Though women smokers have a lower rate of lung cancer death, women who smoke appear to be more susceptible to lung cancer than men who smoke.